Skip to main content
Premium Trial:

Request an Annual Quote

Edwin Southern, Peter Boatright, Tim McGrath, Robert Monaghan, Lawrence Cohen, Dade Behring, Pieter Strijkert, Jean Deleage

Premium

Microarray pioneer Edwin Southern, biochemistry professor at Oxford University, was honored with knighthood last week on the occasion of the birthday of Queen Elizabeth II.

Peter Boatright and Tim McGrath were named to the board of directors of Lark Technologies, a Houston-based provider of genomic services, and will serve until August, when they will be eligible for election to the board. McGrath is the CEO for Houston-based Xeotron and the former president of Sigma-Genosys. Boatright is a retired attorney and a certified public accountant and serves on the boards of Guaranty Credit Card and Americrest Bank of Oklahoma City, Okla.

Robert Monaghan was named chief executive officer for Hayward, Calif.-based Zyomyx, replacing Lawrence Cohen, who moves to the position of vice chairman of the company. Monaghan previously served as president of Sigma Diagnostics, as well as its subsidiaries, and supervised the sale of the company in 2002. He also has served as a vice president of R&D at Dade Behring; vice president of sales at Behring Diagnostics; and in business development, marketing, and sales positions with: SYVA, a division of Syntex Pharmaceuticals; Ciba Corning Diagnostics; Health Charge Corporation; hospital finance consulting group Amherst Associates; and the American Hospital Supply Corporation.

Pieter Strijkert has resigned as chairman of PamGene’s supervisory board, the Hertogenbosch, Netherlands company said. Jean Deleage, a board member of the company since 2000, has been appointed interim chair. Deleage is a managing general partner and founding member of venture capital firm Alta Partners, which led PamGene’s original $6.4 million equity financing round in 2000. Deleage was previously managing partner of VC firm Burr, Egan, Deleage.

 

 

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.